ArticlePatient preference and adherence2021

Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment.

Kathleen Beusterien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.